Li M - Search Results

1

[Inhibitory effect of oxaliplatin in combination with hyperthermia on angiogenesis].

Qian XP, Liu BR, Li M, Hu J, Hu WJ, Zou ZY, Wang LF, Yu LX. Qian XP, et al. Among authors: li m. Zhonghua Zhong Liu Za Zhi. 2007 Nov;29(11):826-9. Zhonghua Zhong Liu Za Zhi. 2007. PMID: 18396639 Chinese.

2

[Pilot study on the mechanisms of growth inhibitory effect of cinobufagin on HeLa cells].

Wang L, Wu J, Li M, Yang XW, Cui JR. Wang L, et al. Among authors: li m. Zhonghua Zhong Liu Za Zhi. 2005 Dec;27(12):717-20. Zhonghua Zhong Liu Za Zhi. 2005. PMID: 16483480 Chinese.

3

[Inhibitory effect of tetrandrine on angiogenesis].

Qian XP, Liu BR, Hu J, Li M, Hu WJ, Sun J, Yu LX. Qian XP, et al. Among authors: li m. Ai Zheng. 2008 Oct;27(10):1050-5. Ai Zheng. 2008. PMID: 18851784 Free article. Chinese.

4

Rhizoma Paridis ethanol extract selectively inhibits the proliferation of HUVECs comparing to Lovo cells and shows anti-angiogenesis effects in a mouse model.

Qian X, Zhu L, Hu J, Li M, Xie L, Wang L, Yu L, Liu B. Qian X, et al. Among authors: li m. J Ethnopharmacol. 2012 Aug 30;143(1):256-61. doi: 10.1016/j.jep.2012.06.032. Epub 2012 Jun 28. J Ethnopharmacol. 2012. PMID: 22750432

5

miR‑1273g‑3p promotes proliferation, migration and invasion of LoVo cells via cannabinoid receptor 1 through activation of ERBB4/PIK3R3/mTOR/S6K2 signaling pathway.

Li M, Qian X, Zhu M, Li A, Fang M, Zhu Y, Zhang J. Li M, et al. Among authors: li a. Mol Med Rep. 2018 Mar;17(3):4619-4626. doi: 10.3892/mmr.2018.8397. Epub 2018 Jan 9. Mol Med Rep. 2018. PMID: 29328379

6

UBE2S promotes the progression and Olaparib resistance of ovarian cancer through Wnt/β-catenin signaling pathway.

Hu W, Li M, Chen Y, Gu X. Hu W, et al. Among authors: li m. J Ovarian Res. 2021 Sep 17;14(1):121. doi: 10.1186/s13048-021-00877-y. J Ovarian Res. 2021. PMID: 34535173 Free PMC article.

7

Linalool Impress Colorectal Cancer Deterioration by Mediating AKT/mTOR and JAK2/STAT3 Signaling Pathways.

Hou M, Zhang Y, Huang Q, Zhan H, Jia T, Li M, Hu J, Zhao Y. Hou M, et al. Among authors: li m. Biomed Res Int. 2022 Jul 11;2022:4801703. doi: 10.1155/2022/4801703. eCollection 2022. Biomed Res Int. 2022. Retraction in: Biomed Res Int. 2023 Jun 21;2023:9782959. doi: 10.1155/2023/9782959 PMID: 35860797 Free PMC article. Retracted.

8

The Immune-microenvironment Confers Chemoresistance of Colorectal Cancer through Macrophage-Derived IL6.

Yin Y, Yao S, Hu Y, Feng Y, Li M, Bian Z, Zhang J, Qin Y, Qi X, Zhou L, Fei B, Zou J, Hua D, Huang Z. Yin Y, et al. Among authors: li m. Clin Cancer Res. 2017 Dec 1;23(23):7375-7387. doi: 10.1158/1078-0432.CCR-17-1283. Epub 2017 Sep 19. Clin Cancer Res. 2017. PMID: 28928161

9

METTL3 antagonizes 5‑FU chemotherapy and confers drug resistance in colorectal carcinoma.

Li M, Xia M, Zhang Z, Tan Y, Li E, Guo Z, Fang M, Zhu Y, Hu Z. Li M, et al. Among authors: li e. Int J Oncol. 2022 Sep;61(3):106. doi: 10.3892/ijo.2022.5396. Epub 2022 Jul 20. Int J Oncol. 2022. PMID: 35856434 Free PMC article.

10

[Z-ajoene causes cell cycle arrest at G2/M and decrease of telomerase activity in HL-60 cells].

Ye Y, Yang HY, Wu J, Li M, Min JM, Cui JR. Ye Y, et al. Among authors: li m. Zhonghua Zhong Liu Za Zhi. 2005 Sep;27(9):516-20. Zhonghua Zhong Liu Za Zhi. 2005. PMID: 16438845 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

75,693 results

Search Page

Filters